1,345
Participants
Start Date
April 30, 2005
Primary Completion Date
March 31, 2007
Study Completion Date
September 30, 2007
T dap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.
Day 0: 0.5 mL (T dap)+ Placebo, Intramuscular; Day 28: 0.5 mL (Menactra®) Intramuscular
Tdap + Meningococcal Polysaccharide Diphtheria Toxoid Conj.
Day 0: 0.5 mL (T dap) + 0.5 mL (Menactra®) Intramuscular; Day 28: Placebo 0.5 mL Intramuscular
Meningococcal Polysaccharide Diphtheria Toxoid Conj. + T dap
Day 0: 0.5 mL (Menactra®)+0.5 mL Placebo, Intramuscular; Day 28: 0.5 mL (T dap) Intramuscular
Syracuse
Pittsburgh
Sellersville
Baltimore
Raleigh
Sylva
Marietta
Woodstock
Kingsport
Bardstown
Columbus
Cleveland
Akron
Dayton
Little Rock
Jonesboro
Boulder
Albuquerque
Spokane
Woburn
Sanofi Pasteur, a Sanofi Company
INDUSTRY